Novartis AG

Switzerland


 
Total IP 11,202
Total IP incl. subs 19,786 (+ 8,806 for subs)
Total IP Rank # 78
IP Activity Score 4.3/5.0    4,817
IP Activity Rank # 116
IP AS incl. subs 4.3/5.0    8,451
Stock Symbol
ISIN CH0012005267
Market Cap. 178.7B  (CHF)
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

1,835 1,259
706 826
3,494 2,073
1,009
 
Last Patent 2025 - Immunosuppressant formulations
First Patent 1973 - O-substituted 7.beta.-amino-3-ce...
Last Trademark 2025 - QYNETRU
First Trademark 1942 - METHERGINE

Subsidiaries

99 subsidiaries with IP (5956 patents, 2850 trademarks)

72 subsidiaries without IP

 Register for free to unlock the subsidiary list

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 G/S Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal prep...
G/S Pharmaceutical preparations.
G/S providing an internet website portal offering the sale of products in the field of health and med...
2024 Invention Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide poly...
G/S Logiciels téléchargeables pour la fourniture d'informations médicales et pharmaceutiques aux pati...
G/S Downloadable software for use in providing medical and pharmaceutical information for patients; d...
G/S Downloadable software for use in providing medical and pharmaceutical information for patients; ...
Invention Means and method for preparing viral vectors and uses of same. Methods for preparing and purifyi...
G/S Préparations pharmaceutiques pour la prévention et le traitement du système nerveux central, à sa...
G/S Services de conseils en affaires dans le domaine de la mise en place, de la pratique et du foncti...
G/S Business consulting services in the field involving the implementation, practice and operation of...
G/S Business consulting services in the field involving the implementation, practice and operation o...
G/S Business consulting services in the field of set-up, practice and operation of radioligand imagi...
G/S Business consulting services in the field of set-up, practice and operation of radioligand imagin...
Invention Antibody drug conjugates for ablating hematopoietic stem cells. The present invention provides a...
G/S Providing a web site featuring medical information; providing medical information in the field of...
Invention S1p modulator immediate release dosage regimen. The present invention relates to siponimod (BAB3...
Invention Nlrp3 inflammasome inhibitors. The present invention relates to novel pyridazin-3-yl phenol comp...
Invention Dosage regimens for anti-pd-l1 antibodies and uses thereof. Antibody molecules that specifically...
Invention 3-(5-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof. The present di...
Invention Methods of using factor b inhibitors. Described herein are methods of treating gMG (generalized M...
Invention Immunosuppressant formulations. The present invention relates to a solid phase pharmaceutical co...
Invention Fap targeting cyclic peptides and conjugates thereof. Described herein are cyclic peptides target...
Invention Compounds and compositions for modulating the activity of erk. The invention relates to compounds...
Invention Selective reduction of cysteine residues in il-17 antibodies. The present disclosure relates to ...
Invention Compositions and methods of use for therapeutic antibodies. The present invention relates to ant...
Invention Human mesothelin chimeric antigen receptors and uses thereof. Provided are compositions and meth...
Invention New uses of omalizumab. 150mg/mL omalizumab formulation for use in a method of treatment of one o...
Invention Polyomavirus neutralizing antibodies. The present invention relates to anti-VP1 antibodies, anti...
Invention Psma-targeting radioligand treatment regimen. Described herein are radiopharmaceuticals for the t...
Invention Method of treating prostate cancer. The present disclosure relates to a method of treating prosta...
Invention Sodium channel blockers. The present disclosure relates to sulfonamide compounds, the use thereo...
Invention Sodium channel blockers. The present disclosure relates to sulfonamide compounds, the use thereof...
Invention 10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1 ',2':4,5]pyrazino[1,2-b]pyridaz...
Invention Anti-ige antibody therapy for multiple food allergies. The present disclosure provides methods a...
Invention Bispecific antibodies for use in treatment of patients with xiap deficiency or cdc42 mutations. T...
Invention Method and apparatus for using omalizumab. A method of treating a patient with of one or more of...
Invention Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections. The invention ...
Invention Combination. A novel combination comprising a 17 α-hydroxylase/C17,20 lyase inhibitor, for examp...
Invention Antibody molecules to pd-1 and uses thereof. Antibody molecules that specifically bind to PD-1 a...
Invention Digital solutions for differentiating asthma from copd. The present disclosure relates generally...
Invention Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such ...
Invention Il-18 binding molecules. IL-18 participates in both innate and acquired immunity. The bioactivit...
Invention Methods of treating non-radiographic axial spondyloarthritis using interleukin-17 (il-17) antagon...
Invention Immunosuppressant formulation. The present invention concerns a dosage form, preferably for imme...
Invention Methods of using factor b inhibitors. Described herein are methods of treating paroxysmal noctur...
Invention Heteroaromatic nmda receptor modulators and uses thereof. Provided is 5-(3-chloro-4-fluorophenyl...
Invention Compositions and methods for increasing muscle growth. This disclosure is in the field of anti-A...
Invention Methyl 2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1h-cyclopenta[b]pyridine-3-carboxylate ...
2023 Invention Methods of treating chronic spontaneous urticaria using ligelizumab. The present disclosure rela...
Invention Tetrahydro-pyrido-pyrimidine derivatives. The invention relates to substituted tetrahydro-pyrido...
Invention Anti-ige antibody therapy for multiple food allergies. The present disclosure provides methods an...
Invention Stable and soluble antibodies inhibiting vegf. The present invention relates to soluble and stab...
2022 Invention Pyridine-3-carboxylate compounds as cav1.2 activators. The present disclosure provides for a com...
Invention Methods of treatment using lou064. The present disclosure relates to methods of treating and/or ...
Invention Staggered triple lipid-modified nucleic acid compounds. Disclosed herein are compounds including...
Invention Combination therapy for treating lung cancer. The present invention relates to methods for treat...
Invention Methods for determining the biological activity of angptl polypeptides. Provided herein are meth...
Invention Engineered fc variants. The present invention describes engineered immunoglobulin IgG Fc regions...
Invention Crystalline forms of biaryl yap/taz-tead protein-protein interaction inhibitors. The present inv...
Invention Dosing regimen for an nlrp3 inhibitor in the treatment of osteoarthritis. The present disclosure...
2019 Invention Novel dosing regimens for mdm2 inhibitors. The present invention relates to the HDM2-p53 interac...